recombin
viral
vector
use
tool
aid
vaccin
develop
howev
express
envelop
gene
use
viral
vector
success
induct
potent
neutral
antibodi
vivo
took
advantag
strong
immunogen
vesicular
stomat
viru
vsv
base
vector
express
gene
recombin
vsv
result
show
protein
express
recombin
vsv
retain
nativ
conform
protein
degre
recogn
two
wellcharacter
broad
neutral
monoclon
antibodi
show
one
time
intranas
immun
recombin
vsv
led
product
antisera
mice
addit
found
antisera
abil
neutral
envelopepseudotyp
virus
also
pseudotyp
virus
jrfl
envelop
result
suggest
express
recombin
vsv
combin
rout
intranas
administr
effect
strategi
evalu
immunogen
envelop
protein
variant
mice
wide
accept
cellular
humor
immun
import
vaccin
develop
review
refer
studi
shown
infect
vaccin
macaqu
capabl
stimul
strong
cellular
immun
respons
contrast
cellular
immun
respons
neutral
antibodi
difficult
induc
great
challeng
obtain
broad
high
titer
neutral
antibodi
aid
vaccin
develop
target
neutral
antibodi
trimer
envelop
protein
nativ
virion
structur
envelop
glycoprotein
particularli
primari
isol
evolv
minim
elicit
efficaci
neutral
antibodi
principl
possibl
genet
reengin
immunoevas
envelop
protein
convert
immunostimulatori
vaccin
antigen
sever
report
indic
specif
modif
introduc
envelop
may
increas
immunogen
stimul
anim
produc
broadli
neutral
antibodi
modif
includ
loop
delet
introduct
uniqu
promet
mutat
tip
envelop
remov
select
nlink
glycosyl
site
develop
optim
immunogen
envelop
vaccin
requir
extens
modif
envelop
protein
highthroughput
screen
potenti
immunogen
larg
amount
requir
envelop
protein
use
immun
length
time
requir
matur
neutral
antibodi
dna
vaccin
constrain
develop
highthroughput
screen
immunogen
differ
envelop
mutat
therefor
method
induc
rapid
potent
neutral
antibodi
need
test
number
potenti
immunogen
multipl
vaccin
approach
explor
date
robust
protect
immun
gener
live
attenu
viru
vaccin
live
recombin
virus
use
evalu
effect
envelop
protein
induc
protect
immun
review
vesicular
stomat
viru
vsv
member
rhabdoviru
famili
nonseg
negativestrand
rna
viru
develop
system
recov
vsv
cdna
allow
manipul
vsv
genom
express
foreign
gene
recombin
vsv
number
gene
differ
virus
insert
recombin
vsv
vector
recombin
vsv
produc
use
immunogen
immun
anim
stimul
strong
immun
respons
particular
viru
recombin
vsv
vector
also
use
vaccin
develop
particular
recombin
vsv
express
env
gag
protein
use
immun
macaqu
shown
gener
protect
immun
shiv
challeng
current
studi
develop
screen
strategi
use
antigenexpress
recombin
vsv
singl
dose
intranas
immun
mice
also
use
pseudotyp
report
virus
determin
titer
neutral
antibodi
result
show
method
could
serv
effect
rapid
altern
approach
examin
effect
mutat
product
neutral
antibodi
plasmid
viral
rna
extract
collect
vsv
indiana
serotyp
gift
dr
michael
whitt
univers
tennesse
cultur
supernat
qiagen
qiaamp
rna
mini
kit
qiagen
valencia
ca
five
fragment
vsv
genom
gener
rtpcr
assembl
fulllength
cdna
pbluescript
sk
strategen
la
jolla
ca
modifi
insert
termin
novagen
madison
wi
xbaisaci
site
name
skter
fulllength
cdna
vsv
insert
promot
ribozym
sequenc
hepat
delta
viru
skter
two
complementari
oligonucleotid
contain
transcript
stopstart
sequenc
xhoi
site
clone
nhei
site
g
l
gene
result
plasmid
design
pvsv
plasmid
name
pskn
pskp
pskl
construct
clone
n
p
l
gene
pskter
xhoixbai
site
gene
modifi
signal
peptid
tpa
gift
prof
jame
mullin
univers
washington
school
medicin
use
substitut
signal
peptid
transmembran
region
cytoplasm
tail
vsvglycoprotein
vsvg
ad
c
terminu
fusion
gene
encod
aa
clone
pvsv
plasmid
use
xhoi
nhei
site
result
plasmid
design
meanwhil
green
fluoresc
protein
gfp
gene
clontech
palo
alto
ca
luciferas
gene
also
clone
pvsv
respect
design
pvsvegfp
pvsvluc
recoveri
recombin
vsv
cell
american
type
cultur
collect
manassa
va
maintain
modifi
medium
dmem
supplement
fetal
bovin
serum
nearli
confluent
cell
confluenc
infect
gift
prof
bernard
moss
niaid
nih
recombin
vaccinia
viru
express
rna
polymeras
multipl
infect
moi
sixti
minut
infect
cell
transfect
lg
pvsvn
pvsvp
lg
pvsvl
lg
pvsvegfp
pvsvluc
pvsvfl
use
lipofectamin
transfect
kit
accord
instruct
invitrogen
carlsbad
ca
cell
incub
co
incub
h
cell
cultur
dish
frozenthaw
three
time
supernat
collect
centrifug
min
debri
remov
pass
lm
filter
supernat
ad
fresh
cell
ratio
ml
per
cm
dish
incub
cell
h
one
millilit
supernat
collect
cell
ad
anoth
plate
fresh
cell
recoveri
recombin
infecti
vsv
perform
h
later
confirm
develop
cytopath
effect
cpe
cell
recombin
vsv
propag
cell
store
titer
recombin
vsv
determin
pfuml
use
standard
plaqu
assay
recombin
vsvluc
determin
luciferas
activ
infect
cell
plate
recombin
vsvegfp
determin
gfp
express
fluoresc
microscop
western
blot
recombin
vsvegfp
use
infect
cell
moi
h
cell
exhibit
visibl
cpe
still
attach
plate
cell
gentli
rins
pb
lyse
sd
load
buffer
protein
electrophoret
separ
sdspolyacrylamid
gel
sdspage
transfer
nitrocellulos
membran
amersham
piscataway
nj
membran
block
milk
ttb
mm
trishcl
ph
nacl
tween
h
sheep
antiserum
obtain
nation
institut
health
aid
research
refer
reagent
program
overnight
probe
alkalin
phosphataseconjug
secondari
antibodi
protein
membran
visual
use
bcipnbt
solut
promega
madison
wi
flow
cytometri
wildtyp
vsv
recombin
use
infect
bhk
cell
cell
began
show
cpe
occur
h
postinfect
cell
collect
wash
pb
stain
human
monoclon
antibodi
obtain
nation
institut
health
aid
research
refer
reagent
program
ice
h
fitcconjug
goat
antihuman
igg
santa
cruz
santa
cruz
ca
unrel
human
igg
gift
dr
johnni
indiana
univers
includ
immunostain
control
cell
analyz
flow
cytomet
dakocytom
fortcollin
co
mous
immun
femal
balbc
mice
hous
anim
center
peke
univers
school
medicin
use
protocol
approv
institut
anim
use
care
committe
anim
kept
filterisolett
cage
anim
facil
peke
univers
school
medicin
fiveto
sixweekold
mice
intranas
immun
pfu
dilut
dmem
vsvegfp
use
immun
control
dmem
alon
use
mock
three
group
total
group
mice
serum
prepar
blood
sampl
collect
week
follow
immun
allow
clot
overnight
clot
remov
centrifug
min
sera
transfer
steril
eppendorf
tube
heatinactiv
min
sera
store
detect
antibodi
sera
product
antibodi
envelop
detect
bind
abil
mice
sera
cell
transient
express
envelop
gene
twenti
microgram
transfer
obtain
nation
institut
health
aid
research
refer
reagent
program
cm
dish
cell
calcium
phosphatemedi
transfect
h
cell
collect
wash
twice
pb
express
envelop
determin
stain
antibodi
use
fac
analysi
normal
human
igg
concentr
use
control
mice
sera
analyz
fac
preimmun
sera
use
neg
control
neutral
assay
neutral
activ
determin
incub
pseudotyp
virus
sera
monitor
inhibit
infect
pseudotyp
virus
describ
briefli
luciferas
report
virus
e
pseudotyp
jrfl
envelop
protein
incub
sera
dilut
h
use
infect
jrfl
cell
micropl
well
flat
bottom
pseudotyp
luciferas
report
virus
without
antiserum
treatment
includ
control
cell
allow
incub
day
lyse
luciferas
activ
assay
use
luciferas
assay
system
promega
madis
wi
wallac
microbetta
counter
perkinelm
boston
neutral
activ
mous
sera
sarscov
use
control
serum
specif
use
similar
assay
addit
immun
serum
sampl
compar
serum
given
mice
immun
test
nonspecif
neutral
activ
neutral
experi
perform
duplic
repeat
least
twice
neutral
abil
sera
group
calcul
subtract
mean
luminesc
cell
infect
pseudotyp
virus
serum
treatment
cell
infect
pseudotyp
virus
without
serum
treatment
express
fraction
cell
infect
pseudotyp
virus
without
sera
treatment
neg
control
reactiv
immun
sera
sarscov
pseudotyp
viru
express
infect
rate
calcul
mean
luminesc
cell
infect
sarscov
pseudotyp
viru
treat
immun
sera
divid
mean
luminesc
cell
infect
sarscov
pseudotyp
viru
without
sera
treatment
five
fragment
vsv
genom
obtain
rtpcr
assembl
fulllength
cdna
cdna
clone
modifi
pbluescript
sk
vector
control
promot
termin
gener
correct
end
vsv
ribozym
sequenc
hepat
delta
viru
introduc
downstream
vsv
trailer
sequenc
order
facilit
clone
foreign
gene
linker
contain
minim
transcript
start
stop
sequenc
restrict
endonucleas
site
insert
g
l
gene
whole
plasmid
name
pvsv
fig
success
recov
infecti
vsv
rvsv
detail
materi
method
viru
purifi
infect
cell
supernat
shown
express
five
protein
l
g
p
n
fig
pattern
wildtyp
vsv
test
foreign
gene
could
express
vector
construct
recov
recombin
vsv
contain
egfp
egfp
express
confirm
fluoresc
microscop
data
shown
confirm
foreign
gene
abl
express
vector
construct
recov
recombin
vsv
contain
luciferas
gene
measur
luciferas
activ
cell
infect
vsvluc
luciferas
activ
cell
infect
vsv
use
neg
control
fig
data
indic
pvsv
could
use
gene
deliveri
carrier
made
modifi
version
replac
signal
peptid
tpa
ad
transmembran
region
cytoplasmat
tail
vsvg
c
terminu
first
insert
modifi
egfp
gene
vsv
vector
success
recov
recombin
vsvegfp
virus
wildtyp
vsv
passag
cell
follow
initi
transfect
cell
inocul
recombin
virus
show
typic
cpe
within
h
passag
titer
recombin
vsv
virus
found
rang
wildtyp
vsv
virus
ie
pfuml
assess
plaqu
assay
express
recombin
vsv
infect
cell
confirm
western
blot
assay
use
antiserum
fig
also
found
express
surfac
recombin
infect
cell
epitop
cell
surfac
recogn
neutral
antibodi
cell
surfac
stain
fac
analysi
fig
stain
specif
stain
detect
cell
infect
wildtyp
vsv
one
advantag
use
recombin
vsv
abil
induc
strong
immun
respons
vivo
also
virus
could
intranas
administ
mice
singl
dose
nevertheless
recombin
virus
also
shown
induc
high
titer
antivsv
neutral
antibodi
due
high
level
vsvg
protein
express
within
virus
agreement
find
result
show
sera
obtain
immun
mice
high
titer
antivsv
neutral
antibodi
inhibit
infect
vsvg
pseudotyp
virus
dilut
higher
data
shown
investig
abil
recombin
induc
antibodi
use
sera
immun
mice
week
preimmun
sera
primari
antibodi
stain
cell
transient
transfect
envelop
express
vector
cell
abl
stain
neutral
antibodi
normal
human
igg
dilut
sera
mice
immun
bound
cell
transfect
envelop
gene
sera
mice
immun
vsvegfp
preimmun
sera
show
bind
activ
fig
data
suggest
immun
produc
antibodi
determin
whether
obtain
sera
neutral
activ
measur
inhibitori
effect
sera
infect
perform
singleround
infect
cell
use
luciferas
report
virus
treat
without
sera
also
includ
neutral
antibodi
posit
unrel
antibodi
nativ
protein
epitop
well
expos
epitop
cryptic
control
experi
agreement
publish
data
neutral
jrfl
ic
lgml
neutral
ic
lgml
respect
sera
immun
jrfl
neutral
antibodi
fig
reach
peak
week
immun
fig
describ
screen
strategi
base
recombin
vsv
evalu
immunogen
envelop
studi
confirm
foreign
gene
engin
vsv
recombin
vsv
express
envelop
induc
neutral
antibodi
singl
intranas
inocul
immun
mice
recombin
vsv
express
variou
envelop
envelop
mutat
detect
neutral
abil
isol
standard
assay
panel
serv
effect
rapid
altern
approach
determin
better
immunogen
elicit
neutral
antibodi
strategi
could
facilit
vaccin
develop
one
advantag
rvsv
vector
high
titer
recombin
vsv
experi
recombin
vsv
express
luc
egfp
recov
passag
cell
time
determin
plaqu
assay
titer
pfuml
respect
titer
lower
recov
wildtyp
vsv
pfuml
within
rang
anoth
advantag
vsvbase
vector
recombin
vsv
stimul
strong
cellular
humor
immun
respons
recombin
vsv
express
gag
envelop
protein
form
viru
like
particl
induc
high
level
ctl
respons
gag
envelop
experi
intranas
inocul
recombin
vsv
express
induc
antibodi
bind
envelop
protein
express
cell
surfac
antisera
mice
could
neutral
jrfl
pseudotyp
report
virus
titer
neutral
measur
ic
titer
neutral
jrfl
sera
specif
inhibit
envelop
pseudotyp
virus
sinc
inhibit
sarscov
spike
pseudotyp
viru
entri
host
cell
neutral
titer
rang
dna
immun
result
modifi
ad
three
copi
c
molecular
adjust
dna
immun
need
boost
dna
twice
first
immun
boost
protein
two
time
dna
immun
requir
least
month
develop
neutral
antibodi
recombin
vsv
immun
detect
neutral
antibodi
week
peak
week
short
time
matur
neutral
antibodi
make
method
conveni
evalu
envelop
immunogen
recombin
vsv
express
surfac
infect
cell
shown
fig
express
identifi
western
blot
cell
lyse
fac
analysi
mab
data
confirm
modifi
cell
surfac
kept
conform
may
import
induc
neutral
antibodi
although
detect
express
infect
cell
detect
recombin
virion
pellet
virus
compar
viral
protein
express
within
recombin
virus
found
recombin
vsv
virion
express
l
np
protein
similar
level
wild
vsv
coomassiestain
sdspage
data
show
howev
abl
detect
presenc
within
recombin
vsv
virion
result
consist
previou
data
rvsv
express
envelop
high
level
vsv
g
protein
much
lower
vsv
g
protein
level
incorpor
recombin
vsv
virion
lower
level
inocul
envelop
protein
quit
differ
compar
foreign
protein
express
rvsv
describ
previous
protein
measl
viru
hemagglutinin
effect
incorpor
virion
lower
incorpor
may
due
intracellular
retent
degrad
envelop
reach
cell
surfac
enhanc
immunogen
envelop
protein
express
rvsv
new
recombin
vsv
vector
encod
costimulatori
molecul
cytokin
express
envelop
protein
coval
link
c
develop
test
improv
vsv
vector
envelop
antigen
effect
present
easi
immun
addit
neutral
antibodi
detect
within
shorter
time
recombin
vsv
express
envelop
envelop
mutat
make
highthroughput
comparison
possibl
